trial · primary record
Metformin
Inflammatory Bowel Diseases
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2023-12-01 |
| Primary endpoint | The primary endpoint is the change in partial mayo score index |
| Registry ID | NCT05553704 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:40.438Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05553704
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.